BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1512532)

  • 1. Current perspectives on papillary carcinoma of the thyroid gland.
    Chiu MK; Sherry RM; Wei JP
    J Med Assoc Ga; 1992 Aug; 81(8):442-4. PubMed ID: 1512532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
    Engel U; Kucharski A; Zornig C
    Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary microcarcinoma of the thyroid.
    Shaha AR; Tuttle RM; Shah JP
    J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid papillary hyperplasia mistaken for papillary carcinoma in fine needle aspiration cytology and frozen section examination].
    Flikweert ER; Nugteren WA; Groote AD
    Ned Tijdschr Geneeskd; 2003 Mar; 147(11):510-3. PubMed ID: 12677951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
    Cheema Y; Olson S; Elson D; Chen H
    J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary: Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma.
    Terris DJ
    Head Neck; 2010 Jun; 32(6):698-9. PubMed ID: 20187017
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of preoperative radioactive iodine (131I) therapy for locally advanced papillary thyroid cancer: a case report.
    Shingu K; Kobayashi S; Yokoyama S; Shimizu T; Kasuga Y; Fujimori M; Ito K; Hama Y; Amano J
    Thyroid; 1998 Dec; 8(12):1113-6. PubMed ID: 9920366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined surgical and radiotherapeutic treatment of papillary and follicular thyroid carcinoma].
    Jadoul D; Glanzmann C; Lütolf U; Hahnloser P
    Helv Chir Acta; 1976 Dec; 43(5-6):635-40. PubMed ID: 826510
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
    Lin JD; Chao TC; Hsueh C
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary carcinoma of a thyroglossal duct remnant with Hashimoto's thyroiditis.
    Prasad ML; Rangaswamy M; Kumar N; Shukla NK
    Ear Nose Throat J; 1990 May; 69(5):358-60. PubMed ID: 2379481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up of papillary and follicular thyroid cancer--when and where?].
    Mäenpää HO; Välimäki MJ
    Duodecim; 2010; 126(20):2424-30. PubMed ID: 21125756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
    Baranauskas ZL; Mamontov VV; Valutskas KK
    Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical treatment of differentiated carcinoma of the thyroid. Retrospective study].
    Gutiérrez JM; Fernández A; Eire PF; Mariño JM; Olivas JM; Alonso LA; Peramato PG; Pereira PL; Queizán A; Utrilla JG
    Cir Pediatr; 1990 Apr; 3(2):73-5. PubMed ID: 2252852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.